Glasgow Firm Joins Fight Against Cancer

DeepMatter wins contract to supply DigitalGlassware system for use in the drug discovery process.

05:10 27 April 2020

The renowned Cancer Research UK Beatson Institute in Glasgow has partnered with DeepMatter. 

 

DeepMatter is the creator of the DigitalGlassware system, a platform where chemists can record and store huge amounts of data about experiments online so they can be shared with others on the internet. The technology will be used by the Beatson Institute's drug discovery unit to share research output with chemistry specialists in China. 

 

DeepMatter said: "The use of DigitalGlassware means the Drug Discovery Unit will be able to share its cutting-edge chemistry across locations, so that work is not needlessly duplicated nor time and money wasted, and ultimately so new discoveries might be made faster."

 

Meanwhile, Justin Bower, Joint Head of the Drug Discovery Unit and Head of Chemistry at the institute said: "DeepMatter's technology is some of the most innovative we have seen to date and we look forward to working with them to test its capabilities." 

 

He added: "We know that improved reproducibility in our work, particularly when achieved across multiple sites, will lead to enhanced productivity and a faster speed of discovery."